or Try an Advanced Search...

    Central Nervous System Disorders Stocks List

    Symbol Grade Name % Change
    PRAX B Praxis Precision Medicines, Inc. -2.37
    NGNE B Neurogene, Inc. 4.68
    RAPP B Rapport Therapeutics, Inc. 0.37
    AXSM C Axsome Therapeutics, Inc. -0.21
    DRRX C DURECT Corporation 1.52
    PRTC D PureTech Health plc 2.36
    MNOV D MediciNova, Inc. -1.19
    VNDA D Vanda Pharmaceuticals Inc. 0.22
    BEAM F Beam Therapeutics Inc. 4.66
    PASG F Passage Bio, Inc. 2.34
    View As Page of Charts
    Related Industries: Biotechnology Conglomerates Drug Manufacturers - Specialty & Generic
    Related Stock Lists: Nervous System Disorders Biopharmaceutical Biotechnology Clinical Development Depression Medicine Pain Schizophrenia Alzheimer's Disease Chemical Compounds Chronic Disease Chronic Pain Depressive Disorder Gene Therapy Insomnia Major Depressive Disorder Medication Organ Systems Organic Compounds Rare Diseases

    Related ETFs - A few ETFs which own one or more of the above listed Central Nervous System Disorders stocks.

    Symbol Grade Name Weight
    IBRN B iShares Neuroscience and Healthcare ETF 4.16
    ARKG D ARK Genomic Revolution Multi-Sector ETF 3.46
    XPH B SPDR S&P Pharmaceuticals ETF 3.3
    GNOM F Global X Genomics & Biotechnology ETF 2.74
    PILL B Direxion Daily Pharmaceutical & Medical Bull 3X Shares ETF 2.35
    View all Central Nervous System Disorders ETFs...
    Compare ETFs
    Compare ARKG to PILL Compare ARKG to XPH Compare IBRN to GNOM

        Central Nervous System Disorders Stocks Recent News

        Date Stock Title
        Nov 1 VNDA Over 200% Stock Upside - Vanda Pharmaceuticals Undervalued With Robust Portfolio And Pipeline: Analyst
        Nov 1 PRAX Praxis Precision Medicines to Announce Third Quarter 2024 Financial Results and Host Conference Call on Wednesday, November 6, 2024
        Oct 31 VNDA Vanda started at buy by H.C. Wainwright, negative enterprise value cited
        Oct 31 VNDA Health Care Roundup: Market Talk
        Oct 31 BEAM Beam Therapeutics (BEAM): Promising Gene Editing Stock with Base Editing Technology
        Oct 30 VNDA Vanda Pharmaceuticals to Announce Third Quarter 2024 Financial Results on November 6, 2024
        Oct 30 BEAM CorMedix (CRMD) Reports Q3 Loss, Tops Revenue Estimates
        Oct 30 PRTC PureTech to Present at Two Upcoming Investor Conferences
        Oct 29 AXSM Axsome Therapeutics Presents Data from Multiple Programs Spanning Its Innovative Neuroscience Portfolio at Psych Congress 2024
        Oct 29 BEAM Beam Therapeutics to Hold Conference Call to Discuss Third Quarter 2024 Financial Results and Abstracts Accepted for Presentation at ASH Annual Meeting
        Oct 28 BEAM We're Interested To See How Beam Therapeutics (NASDAQ:BEAM) Uses Its Cash Hoard To Grow
        Related Industries: Biotechnology Conglomerates Drug Manufacturers - Specialty & Generic
        Related Stock Lists: Nervous System Disorders Biopharmaceutical Biotechnology Clinical Development Depression Medicine Pain Schizophrenia Alzheimer's Disease Chemical Compounds Chronic Disease Chronic Pain Depressive Disorder Gene Therapy Insomnia Major Depressive Disorder Medication Organ Systems Organic Compounds Rare Diseases
        Central Nervous System Disorders

        Central Nervous System Disorders are conditions that affect the brain, spinal cord, and nerves. These disorders can cause a wide range of symptoms, including impaired movement, vision, speech, and sensation. Examples of Central Nervous System Disorders include Alzheimer's disease, Parkinson's disease, multiple sclerosis, epilepsy, and stroke.

        Browse All Tags